soul trial oral semaglutide cardiovascular outcomes 2024 nejm results and in... : New England Journal of Medicine Long-term kidney outcomes of semaglutide – soul trial oral semaglutide cardiovascular

doi: 10.1046/j.1365-2249.1999.01009.x 40 ChenK.-K.MinakuchiM.WuputraK.KuC.-C.PanJ.-B.KuoK.-K.et al

Serious adverse events are rare when protocols are supervised by a qualified clinician

& Klein, J

Intermittent fasting from dawn to sunset for 4 weeks is associated with an anticancer serum proteomic signature This pilot study has important clinical implications, specifically from the standpoint of type of intermittent fasting on cancer prevention in subjects with metabolic syndrome

In January 2023, comedian Rosie O'Donnell said she had lost 10 pounds since Christmas by taking tirzepatide and drinking less soda

Kathryn Kline explains DEXA screening, T-scores, and the treatments that actually prevent fractures